Analyses with adoptively transferred melanoma-specific T cells revealed that DTA-1 treatment reduced the accumulation of GITR-expressing, but not GITR-negative Treg in the tumor, while numbers in spleen and draining lymph nodes were not altered. This evidence concerns the gene TNFRSF18 and melanoma.